Skip to main content
. 2021 Oct 18;65(11):e00985-21. doi: 10.1128/AAC.00985-21

TABLE 4.

Immunoprophylactic efficacy linked with drug exposurea

Compound 24-h AUC/MIC Burden reduction (%) (SD)
CTC-171 12.1 87.3 (8.9)
CTC-172 3.1 32.0 (50.5)
CTC-173 8.5 40.9 (30.4)
CTC-174 8.8 56.4 (34.9)
a

Average AB 482 and AB 317 24-h AUC/MIC values from Table 3 and percentage bacterial burden reduction calculated from bacterial burdens of AB 482- and AB 317-infected mice relative to PBS-treated control for each infection.